USPTO serial 98529777
AORTAFIT
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUENAS, TAYLOR S
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with AORTAFIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Kornfield
Susan M. Kornfield Bodman PLC201 South Division Street, Suite 400Ann Arbor, MI 48104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; downloadable software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices. | ACTIVE | — |
| 042 | Software as a service (SaaS) services featuring software for evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; software as a service (SaaS) services featuring software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing online non-downloadable software for evaluating patient-specific data, generating case planning information, and proposing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing temporary use of non-downloadable cloud-based software for evaluating patient-specific data, generating case planning information, and proposing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing online non-downloadable software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing temporary use of non-downloadable cloud-based software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices. | ACTIVE | — |
| 044 | Medical assistance and analysis, namely, evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; medical assistance and analysis, namely, evaluating patient- specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 22, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 22, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 22, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 31, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 30, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 30, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 30, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 28, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 28, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 7, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 6, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 6, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 6, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 4, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 1, 2024 | NWAP | NEW APPLICATION ENTERED | — |